Pedro A. Zubizarreta

1881 Combate De Los Pozos Street
B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017).

Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017).

Journal: Leukemia & lymphoma

Published: April 28, 2026

Treatment of migrant children with acute lymphoblastic leukemia in Argentina

Treatment of migrant children with acute lymphoblastic leukemia in Argentina

Journal: Medicina

Published: April 10, 2026

Retinoblastoma in Argentina: study of germline variants of the RB1 gene

Retinoblastoma in Argentina: study of germline variants of the RB1 gene

Journal: Medicina

Published: February 05, 2026

Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina.

Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina.

Journal: Pediatric blood & cancer

Published: December 23, 2025

Cancer Prevalence in Children with Inborn Errors of Immunity: Report from a Single Institution.

Cancer Prevalence in Children with Inborn Errors of Immunity: Report from a Single Institution.

Journal: Journal of clinical immunology

Published: July 27, 2023

Closing the gap: National Argentinian discussion forum on paediatric brain tumours.

Closing the gap: National Argentinian discussion forum on paediatric brain tumours.

Journal: Frontiers in oncology

Published: March 13, 2023

Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases.

Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases.

Journal: Frontiers in pharmacology

Published: September 29, 2021

Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.

Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.

Journal: Pediatric blood & cancer

Published: September 01, 2021

Colorectal carcinoma in children and adolescents.

Colorectal carcinoma in children and adolescents.

Journal: Archivos argentinos de pediatria

Published: December 23, 2020

Intracranial germ cells tumour: a single institution experience in Argentina.

Intracranial germ cells tumour: a single institution experience in Argentina.

Journal: Journal of neuro-oncology

Published: October 31, 2020

Desmoid-type fibromatosis in children. Clinical features, treatment response, and long-term follow-up

Desmoid-type fibromatosis in children. Clinical features, treatment response, and long-term follow-up

Journal: Medicina

Published: October 13, 2020

No benefit of Interfant protocols compared to BFM-based protocols for infants with acute lymphoblastic leukemia. Results from an institution in Argentina.

No benefit of Interfant protocols compared to BFM-based protocols for infants with acute lymphoblastic leukemia. Results from an institution in Argentina.

Journal: Pediatric blood & cancer

Published: December 30, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026